G6PC1 and hepatocellular carcinoma: Studies investigating 18F-FDG in HCC show limited sensitivity (50%–70%) due to similar activities of glycolytic enzymes and glucose 6-phosphatase in liver and well-differentiated HCC, resulting in near-equivalent uptake of 18F-FDG (6).